RT Journal Article
SR Electronic
T1 Ethnic differences of genetic risk and smoking in lung cancer: two prospective cohort studies
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.02.09.23285130
DO 10.1101/2023.02.09.23285130
A1 Zhu, Meng
A1 Lv, Jun
A1 Huang, Yanqian
A1 Ma, Hongxia
A1 Li, Ni
A1 Wei, Xiaoxia
A1 Ji, Mengmeng
A1 Ma, Zhimin
A1 Song, Ci
A1 Wang, Cheng
A1 Dai, Juncheng
A1 Tan, Fengwei
A1 Guo, Yu
A1 Walters, Robin
A1 Millwood, Iona Y.
A1 Hung, Rayjean J.
A1 Christiani, David C.
A1 Yu, Canqing
A1 Jin, Guangfu
A1 Chen, Zhengming
A1 Wei, Qingyi
A1 Amos, Christopher I.
A1 Hu, Zhibin
A1 Li, Liming
A1 Shen, Hongbing
YR 2023
UL http://medrxiv.org/content/early/2023/02/10/2023.02.09.23285130.abstract
AB Background The relative risk of smoking on lung cancer have been reported to be much higher in white population than that in East Asians. However, it’s unknown whether genetic background underlies this disparity between ethnic groups. To assess the role of ethnic differences in genetic factors associated with this phenomenon.Methods We first constructed ethnic-specific polygenic risk scores (PRSs) to quantify individual genetic risk of lung cancer in Chinese and white populations. Then, we compared genetic risk and smoking as well as their interactions on lung cancer between two cohorts, including the China Kadoorie Biobank (CKB) and the UK Biobank (UKB). We also evaluated the absolute risk reduction over a 5-year period.Results 19 SNPs and 23 SNPs were identified to construct the PRSs in Chinese and white populations, and smoking-related loci were only included in white populations. The PRSs were consistently associated with lung cancer risk respectively, but stronger associations were observed in smokers of the UKB (HR 1.26 versus 1.15, P=0.028). A significant interaction between genetic risk and smoking on lung cancer was observed in the UKB (RERI, 11.39 [95% CI, 7.01-17.94]), but not in the CKB. By comparing heavy smokers with nonsmokers, a greater absolute risk reduction was found in the UKB (10.95 versus 7.12 per 1000 person-years, P<0.001), especially for those at high genetic risk.Conclusions In China, tobacco control alone is not enough to reduce the burden of lung cancer, and comprehensive policies should be made to lower its high incidence.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by National Natural Science Foundation of China (81820108028, 91943301, 81922061, 81973123, and 81803306); Research Unit of Prospective Cohort of Cardiovascular Diseases and Cancers, Chinese Academy of Medical Sciences (2019RU038); National Science Foundation for Post-doctoral Scientists of China (Grant No.2018M640466).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Researchers can apply to use the UK Biobank and the China Kadoorie Biobank resource and access the data used. No additional data are available.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesResearchers can apply to use the UK Biobank and the China Kadoorie Biobank resource and access the data used. No additional data are available.APthe attributable proportion because of the interactionCIconfidence intervalCKBthe China Kadoorie BiobankGWASgenome-wide association studyHRhazards ratioICD-10the 10th Revision of International Classification of DiseasesORodds ratioPRSpolygenic risk scoreRERIrelative excess risk due to interactionRRrelative riskSNPsingle-nucleotide polymorphismUKBthe UK Biobank